Mankind Pharma Ltd (MANKIND) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003845,
    "name": "Mankind Pharma",
    "stock_name": "Mankind Pharma",
    "full_name": "Mankind Pharma Ltd",
    "name_url": "stocks-analysis/mankind-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,408.95",
    "chg": 45.45,
    "chgp": "1.92%",
    "dir": 1,
    "prev_price": "2,363.50",
    "mcapval": "98,758.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 543904,
    "symbol": "MANKIND",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE634S01028",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "5.03 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/mankind-pharma-1003845-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Mankind Pharma Ltd Upgraded to Excellent Quality Grade: A Deep Dive into Business Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-upgraded-to-excellent-quality-grade-a-deep-dive-into-business-fundamentals-4002005",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MankindPharmaLt_qualitydot_4002005.png",
        "date": "2026-05-21 08:00:23",
        "description": "Mankind Pharma Ltd has seen a significant upgrade in its quality grading from good to excellent, reflecting marked improvements in its business fundamentals. The pharmaceutical company’s robust growth in sales and earnings, alongside prudent debt management and strong returns on capital, underpin this positive reassessment by MarketsMOJO, which has also upgraded its Mojo Grade from Hold to Buy."
      },
      {
        "title": "Mankind Pharma Ltd Reports Strong Quarterly Performance, Upgrades Financial Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-reports-strong-quarterly-performance-upgrades-financial-trend-4000969",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MankindPharmaLt_fintrenddot_4000969.png",
        "date": "2026-05-20 11:00:33",
        "description": "Mankind Pharma Ltd has demonstrated a marked improvement in its financial performance for the quarter ended March 2026, signalling a positive shift in its growth trajectory. The company’s financial trend score surged from a flat 3 to a robust 15 over the past three months, reflecting significant gains in revenue, profitability, and operational efficiency compared to its historical performance."
      },
      {
        "title": "Mankind Pharma Ltd Sees Robust Trading Activity Amid Sector Outperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-sees-robust-trading-activity-amid-sector-outperformance-4000658",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MankindPharmaLt_most_active_equities_by_value_4000658.png",
        "date": "2026-05-20 10:00:30",
        "description": "Mankind Pharma Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed significant value-driven trading on 20 May 2026, outperforming its sector and demonstrating renewed investor interest following a recent upgrade in its Mojo Grade from Sell to Hold."
      },
      {
        "title": "8,659 Call Contracts at Rs 2,600 Strike on Mankind Pharma Ltd Signal Speculative Upside Ahead of 26 May Expiry",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-surge-in-call-option-activity-ahead-of-may-expiry-4000592",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MankindPharmaLt_most_active_stocks_calls_4000592.png",
        "date": "2026-05-20 10:00:19",
        "description": "On 20 May 2026, Mankind Pharma Ltd witnessed significant call option activity with 8,659 contracts traded at the Rs 2,600 strike price, just above the stock’s closing price of Rs 2,557.90. This surge in call buying coincided with a 3.02% gain in the cash market, suggesting a speculative push for upside in the near term ahead of the 26 May expiry."
      },
      {
        "title": "Rs 2,500 Puts — 2.4% Below Current Price — Draw 3,355 Contracts on Mankind Pharma Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-surge-in-put-option-activity-amid-bearish-hedging-4000589",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MankindPharmaLt_most_active_stocks_puts_4000589.png",
        "date": "2026-05-20 10:00:17",
        "description": "The Rs 2,500 put strike on Mankind Pharma Ltd attracted 3,355 contracts on 20 May 2026, representing significant activity just 2.4% below the current stock price of Rs 2,560.4. This surge in put options comes as the stock outperformed its sector by 2.3% and trades above all major moving averages, suggesting the put activity may be more about protection than outright bearishness."
      },
      {
        "title": "Mankind Pharma Sees Significant Open Interest Surge Amid Bullish Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-significant-open-interest-surge-amid-bullish-market-signals-4000612",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MankindPharmaLt_oi_spurts_by_underlying_4000612.png",
        "date": "2026-05-20 10:00:09",
        "description": "Mankind Pharma Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock outperformed its sector and broader indices, supported by strong volume and positive technical indicators, prompting a reassessment of its investment grade to Hold from Sell."
      },
      {
        "title": "When is the next results date for Mankind Pharma Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-mankind-pharma-ltd-3982496",
        "imagepath": "",
        "date": "2026-05-08 23:17:29",
        "description": "The next results date for Mankind Pharma Ltd is scheduled for 19 May 2026...."
      },
      {
        "title": "Mankind Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mankind-pharma-ltd-is-rated-sell-3977508",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MankindPharmaLt_mojoScore_3977508.png",
        "date": "2026-05-06 10:10:40",
        "description": "Mankind Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Mankind Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mankind-pharma-ltd-is-rated-sell-3962105",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MankindPharmaLt_mojoScore_3962105.png",
        "date": "2026-04-25 10:10:25",
        "description": "Mankind Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 15,
    "sid": "1003845",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/mankind-pharma-1003845"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "15-Jun-2026",
      "details": "Please find attached intimation regarding participation in investor conference by management and officials of the Company",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "08-Jun-2026",
      "details": "Please find attached Intimation regarding Change in Management.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "08-Jun-2026",
      "details": "Allotment of 86778 Equity Shares under Mankind Employee Stock Option Plan 2022 (ESOP PLAN)",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mankind Pharma Ltd has declared <strong>100%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Mankind Pharma Ltd Upgraded to Excellent Quality Grade: A Deep Dive into Business Fundamentals

2026-05-21 08:00:23

Mankind Pharma Ltd has seen a significant upgrade in its quality grading from good to excellent, reflecting marked improvements in its business fundamentals. The pharmaceutical company’s robust growth in sales and earnings, alongside prudent debt management and strong returns on capital, underpin this positive reassessment by MarketsMOJO, which has also upgraded its Mojo Grade from Hold to Buy.

Mankind Pharma Ltd Reports Strong Quarterly Performance, Upgrades Financial Trend

2026-05-20 11:00:33

Mankind Pharma Ltd has demonstrated a marked improvement in its financial performance for the quarter ended March 2026, signalling a positive shift in its growth trajectory. The company’s financial trend score surged from a flat 3 to a robust 15 over the past three months, reflecting significant gains in revenue, profitability, and operational efficiency compared to its historical performance.

Mankind Pharma Ltd Sees Robust Trading Activity Amid Sector Outperformance

2026-05-20 10:00:30

Mankind Pharma Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed significant value-driven trading on 20 May 2026, outperforming its sector and demonstrating renewed investor interest following a recent upgrade in its Mojo Grade from Sell to Hold.

8,659 Call Contracts at Rs 2,600 Strike on Mankind Pharma Ltd Signal Speculative Upside Ahead of 26 May Expiry

2026-05-20 10:00:19

On 20 May 2026, Mankind Pharma Ltd witnessed significant call option activity with 8,659 contracts traded at the Rs 2,600 strike price, just above the stock’s closing price of Rs 2,557.90. This surge in call buying coincided with a 3.02% gain in the cash market, suggesting a speculative push for upside in the near term ahead of the 26 May expiry.

Rs 2,500 Puts — 2.4% Below Current Price — Draw 3,355 Contracts on Mankind Pharma Ltd

2026-05-20 10:00:17

The Rs 2,500 put strike on Mankind Pharma Ltd attracted 3,355 contracts on 20 May 2026, representing significant activity just 2.4% below the current stock price of Rs 2,560.4. This surge in put options comes as the stock outperformed its sector by 2.3% and trades above all major moving averages, suggesting the put activity may be more about protection than outright bearishness.

Mankind Pharma Sees Significant Open Interest Surge Amid Bullish Market Signals

2026-05-20 10:00:09

Mankind Pharma Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock outperformed its sector and broader indices, supported by strong volume and positive technical indicators, prompting a reassessment of its investment grade to Hold from Sell.

When is the next results date for Mankind Pharma Ltd?

2026-05-08 23:17:29

The next results date for Mankind Pharma Ltd is scheduled for 19 May 2026....

Mankind Pharma Ltd is Rated Sell

2026-05-06 10:10:40

Mankind Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Mankind Pharma Ltd is Rated Sell

2026-04-25 10:10:25

Mankind Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

View All News